• Jasper Therapeutics' (JSPR) "Buy" Rating Reaffirmed at HC Wainwright

    Source: Buzz FX / 15 Oct 2024 09:16:11   America/New_York


    Jasper Therapeutics' (JSPR) "Buy" Rating Reaffirmed at HC Wainwright Written by MarketBeat October 15, 2024 Share Link copied to clipboard. Jasper Therapeutics ( NASDAQ:JSPR - Get Free Report ) 's stock had its "buy" rating reissued by stoc
    Read more...
Share on,